The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Epigenetic clocks that quantify rates of aging from DNA methylation patterns across the genome have emerged as a potential biomarker for risk of age-related diseases, like Alzheimer’s disease (AD), ...

This process is mediated by the epigenetic modification of VMP1, where WHSC1L1-induced H3K36me2 recruits DNMT3A, a DNA methylation enzyme, to repress VMP1 transcription, potentially involving ...